| 000 | 01388 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250511181416.0 | ||
| 264 | 0 | _c19921211 | |
| 008 | 199212s 0 0 eng d | ||
| 022 | _a0390-6078 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCarella, A M | |
| 245 | 0 | 0 |
_aHigh-risk acute lymphoblastic leukemia (ALL): is there an alternative approach for increasing the number of cures? _h[electronic resource] |
| 260 |
_bHaematologica _c |
||
| 300 |
_a348-51 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 | _aBlood Component Transfusion |
| 650 | 0 | 4 | _aBlood Transfusion, Autologous |
| 650 | 0 | 4 | _aBone Marrow Transplantation |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aCytarabine _xadministration & dosage |
| 650 | 0 | 4 |
_aEtoposide _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHematopoietic Stem Cell Transplantation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIdarubicin _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xdrug therapy |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aTranslocation, Genetic |
| 650 | 0 | 4 | _aWhole-Body Irradiation |
| 773 | 0 |
_tHaematologica _gvol. 77 _gno. 4 _gp. 348-51 |
|
| 999 |
_c1365280 _d1365280 |
||